Skip to main content
Erschienen in: Critical Care 2/2011

01.04.2011 | Review

Clinical review: Ketones and brain injury

verfasst von: Hayden White, Balasubramanian Venkatesh

Erschienen in: Critical Care | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Although much feared by clinicians, the ability to produce ketones has allowed humans to withstand prolonged periods of starvation. At such times, ketones can supply up to 50% of basal energy requirements. More interesting, however, is the fact that ketones can provide as much as 70% of the brain's energy needs, more efficiently than glucose. Studies suggest that during times of acute brain injury, cerebral uptake of ketones increases significantly. Researchers have thus attempted to attenuate the effects of cerebral injury by administering ketones exogenously. Hypertonic saline is commonly utilized for management of intracranial hypertension following cerebral injury. A solution containing both hypertonic saline and ketones may prove ideal for managing the dual problems of refractory intracranial hypertension and low cerebral energy levels. The purpose of the present review is to explore the physiology of ketone body utilization by the brain in health and in a variety of neurological conditions, and to discuss the potential for ketone supplementation as a therapeutic option in traumatic brain injury.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Fukao T, Lopaschuk GD, Mitchell GA: Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry. Prostaglandins Leukot Essent Fatty Acids 2004, 70: 243-251. 10.1016/j.plefa.2003.11.001PubMed Fukao T, Lopaschuk GD, Mitchell GA: Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry. Prostaglandins Leukot Essent Fatty Acids 2004, 70: 243-251. 10.1016/j.plefa.2003.11.001PubMed
2.
Zurück zum Zitat DeFronzo R, Ferrannini E: Regulation of intermediary metabolism during fasting and feeding. In Endocrinology. Edited by: DeGroot L, Jameson J. Philadelphia: W.B. Saunders; 2001:737-755. DeFronzo R, Ferrannini E: Regulation of intermediary metabolism during fasting and feeding. In Endocrinology. Edited by: DeGroot L, Jameson J. Philadelphia: W.B. Saunders; 2001:737-755.
3.
Zurück zum Zitat Veech RL: The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids 2004, 70: 309-319. 10.1016/j.plefa.2003.09.007PubMed Veech RL: The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids 2004, 70: 309-319. 10.1016/j.plefa.2003.09.007PubMed
4.
Zurück zum Zitat Williamson DH, Lund P, Krebs HA: The redox state of free nicotinamideadenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem J 1967, 103: 514-527.PubMedCentralPubMed Williamson DH, Lund P, Krebs HA: The redox state of free nicotinamideadenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem J 1967, 103: 514-527.PubMedCentralPubMed
5.
Zurück zum Zitat Veech RL, Eggleston LV, Krebs HA: The redox state of free nicotinamideadenine dinucleotide phosphate in the cytoplasm of rat liver. Biochem J 1969, 115: 609-619.PubMedCentralPubMed Veech RL, Eggleston LV, Krebs HA: The redox state of free nicotinamideadenine dinucleotide phosphate in the cytoplasm of rat liver. Biochem J 1969, 115: 609-619.PubMedCentralPubMed
6.
Zurück zum Zitat Bonnefont JP, Specola NB, Vassault A, Lombes A, Ogier H, de Klerk JB, Munnich A, Coude M, Paturneau-Jouas M, Saudubray JM: The fasting test in paediatrics: application to the diagnosis of pathological hypo- and hyperketotic states. Eur J Pediatr 1990, 150: 80-85. 10.1007/BF02072043PubMed Bonnefont JP, Specola NB, Vassault A, Lombes A, Ogier H, de Klerk JB, Munnich A, Coude M, Paturneau-Jouas M, Saudubray JM: The fasting test in paediatrics: application to the diagnosis of pathological hypo- and hyperketotic states. Eur J Pediatr 1990, 150: 80-85. 10.1007/BF02072043PubMed
7.
Zurück zum Zitat Cahill GF, Herrera MG, Morgan AP, Soeldner JS, Steinke J, Levy PL, Reichard GA, Kipnis DM: Hormone-fuel interrelationships during fasting. J Clin Invest 1966, 45: 1751-1769. 10.1172/JCI105481PubMedCentralPubMed Cahill GF, Herrera MG, Morgan AP, Soeldner JS, Steinke J, Levy PL, Reichard GA, Kipnis DM: Hormone-fuel interrelationships during fasting. J Clin Invest 1966, 45: 1751-1769. 10.1172/JCI105481PubMedCentralPubMed
8.
Zurück zum Zitat Owen OE, Felig P, Morgan AP, Wahren J, Cahill GF Jr: Liver and kidney metabolism during prolonged starvation. J Clin Invest 1969, 48: 574-583. 10.1172/JCI106016PubMedCentralPubMed Owen OE, Felig P, Morgan AP, Wahren J, Cahill GF Jr: Liver and kidney metabolism during prolonged starvation. J Clin Invest 1969, 48: 574-583. 10.1172/JCI106016PubMedCentralPubMed
9.
Zurück zum Zitat Garber AJ, Menzel PH, Boden G, Owen OE: Hepatic ketogenesis and gluconeogenesis in humans. J Clin Invest 1974, 54: 981-989. 10.1172/JCI107839PubMedCentralPubMed Garber AJ, Menzel PH, Boden G, Owen OE: Hepatic ketogenesis and gluconeogenesis in humans. J Clin Invest 1974, 54: 981-989. 10.1172/JCI107839PubMedCentralPubMed
10.
Zurück zum Zitat Williamson DH: Ketone body production and metabolism in the fetus and newborn. In Neonatal Physiology. Edited by: Polin R, Fox W. Philadelphia: W.B. Saunders; 1992:330-340. Williamson DH: Ketone body production and metabolism in the fetus and newborn. In Neonatal Physiology. Edited by: Polin R, Fox W. Philadelphia: W.B. Saunders; 1992:330-340.
11.
Zurück zum Zitat Balasse EO, Fery F: Ketone body production and disposal: effects of fasting, diabetes, and exercise. Diabetes Metab Rev 1989, 5: 247-270. 10.1002/dmr.5610050304PubMed Balasse EO, Fery F: Ketone body production and disposal: effects of fasting, diabetes, and exercise. Diabetes Metab Rev 1989, 5: 247-270. 10.1002/dmr.5610050304PubMed
13.
Zurück zum Zitat Williamson DH, Bates MW, Page MA, Krebs HA: Activities of enzymes involved in acetoacetate utilization in adult mammalian tissues. Biochem J 1971, 121: 41-47.PubMedCentralPubMed Williamson DH, Bates MW, Page MA, Krebs HA: Activities of enzymes involved in acetoacetate utilization in adult mammalian tissues. Biochem J 1971, 121: 41-47.PubMedCentralPubMed
14.
Zurück zum Zitat Singer M: Mitochondrial function in sepsis: acute phase versus multiple organ failure. Crit Care Med 2007, 35: S441-S448. 10.1097/01.CCM.0000278049.48333.78PubMed Singer M: Mitochondrial function in sepsis: acute phase versus multiple organ failure. Crit Care Med 2007, 35: S441-S448. 10.1097/01.CCM.0000278049.48333.78PubMed
15.
Zurück zum Zitat Yassen KA, Galley HF, Lee A, Webster NR: Mitochondrial redox state in the critically ill. Br J Anaesth 1999, 83: 325-327.PubMed Yassen KA, Galley HF, Lee A, Webster NR: Mitochondrial redox state in the critically ill. Br J Anaesth 1999, 83: 325-327.PubMed
16.
Zurück zum Zitat Limuro Y, Yamamoto M, Inoue S, Kohno H, Matsumoto Y: Superoxide production by liver macrophages in septic shock model - relation to arterial ketone body ratio. Eur Surg Res 1992, 24: 363-371. 10.1159/000129229 Limuro Y, Yamamoto M, Inoue S, Kohno H, Matsumoto Y: Superoxide production by liver macrophages in septic shock model - relation to arterial ketone body ratio. Eur Surg Res 1992, 24: 363-371. 10.1159/000129229
17.
Zurück zum Zitat Dresing K, Armstrong VW, Leip CL, Streit F, Burchardi H, Sturmer KM, Oellerich M: Real-time assessment of hepatic function is related to clinical outcome in critically ill patients after polytrauma. Clin Biochem 2007, 40: 1194-1200. 10.1016/j.clinbiochem.2007.06.013PubMed Dresing K, Armstrong VW, Leip CL, Streit F, Burchardi H, Sturmer KM, Oellerich M: Real-time assessment of hepatic function is related to clinical outcome in critically ill patients after polytrauma. Clin Biochem 2007, 40: 1194-1200. 10.1016/j.clinbiochem.2007.06.013PubMed
18.
Zurück zum Zitat Levy B, Sadoune LO, Gelot AM, Bollaert PE, Nabet P, Larcan A: Evolution of lactate/pyruvate and arterial ketone body ratios in the early course of catecholamine-treated septic shock. Crit Care Med 2000, 28: 114-119. 10.1097/00003246-200001000-00019PubMed Levy B, Sadoune LO, Gelot AM, Bollaert PE, Nabet P, Larcan A: Evolution of lactate/pyruvate and arterial ketone body ratios in the early course of catecholamine-treated septic shock. Crit Care Med 2000, 28: 114-119. 10.1097/00003246-200001000-00019PubMed
19.
Zurück zum Zitat Pellerin L: How astrocytes feed hungry neurons. Mol Neurobiol 2005, 32: 59-72. 10.1385/MN:32:1:059PubMed Pellerin L: How astrocytes feed hungry neurons. Mol Neurobiol 2005, 32: 59-72. 10.1385/MN:32:1:059PubMed
20.
Zurück zum Zitat Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GF Jr: Brain metabolism during fasting. J Clin Invest 1967, 46: 1589-1595. 10.1172/JCI105650PubMedCentralPubMed Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GF Jr: Brain metabolism during fasting. J Clin Invest 1967, 46: 1589-1595. 10.1172/JCI105650PubMedCentralPubMed
21.
Zurück zum Zitat Casazza JP, Felver ME, Veech RL: The metabolism of acetone in rat. J Biol Chem 1984, 259: 231-236.PubMed Casazza JP, Felver ME, Veech RL: The metabolism of acetone in rat. J Biol Chem 1984, 259: 231-236.PubMed
22.
Zurück zum Zitat VanItallie TB, Nufert TH: Ketones: metabolism's ugly duckling. Nutr Rev 2003, 61: 327-341. 10.1301/nr.2003.oct.327-341PubMed VanItallie TB, Nufert TH: Ketones: metabolism's ugly duckling. Nutr Rev 2003, 61: 327-341. 10.1301/nr.2003.oct.327-341PubMed
23.
Zurück zum Zitat Reichard GA, Owen OE, Haff AC, Paul P, Bortz WM: Ketone-body production and oxidation in fasting obese humans. J Clin Invest 1974, 53: 508-515. 10.1172/JCI107584PubMedCentralPubMed Reichard GA, Owen OE, Haff AC, Paul P, Bortz WM: Ketone-body production and oxidation in fasting obese humans. J Clin Invest 1974, 53: 508-515. 10.1172/JCI107584PubMedCentralPubMed
24.
Zurück zum Zitat Guzman M, Blazquez C: Ketone body synthesis in the brain: possible neuroprotective effects. Prostaglandins Leukot Essent Fatty Acids 2004, 70: 287-292. 10.1016/j.plefa.2003.05.001PubMed Guzman M, Blazquez C: Ketone body synthesis in the brain: possible neuroprotective effects. Prostaglandins Leukot Essent Fatty Acids 2004, 70: 287-292. 10.1016/j.plefa.2003.05.001PubMed
25.
Zurück zum Zitat Auestad N, Korsak RA, Morrow JW, Edmond J: Fatty acid oxidation and ketogenesis by astrocytes in primary culture. J Neurochem 1991, 56: 1376-1386. 10.1111/j.1471-4159.1991.tb11435.xPubMed Auestad N, Korsak RA, Morrow JW, Edmond J: Fatty acid oxidation and ketogenesis by astrocytes in primary culture. J Neurochem 1991, 56: 1376-1386. 10.1111/j.1471-4159.1991.tb11435.xPubMed
26.
Zurück zum Zitat Bixel MG, Hamprecht B: Generation of ketone bodies from leucine by cultured astroglial cells. J Neurochem 1995, 65: 2450-2461. 10.1046/j.1471-4159.1995.65062450.xPubMed Bixel MG, Hamprecht B: Generation of ketone bodies from leucine by cultured astroglial cells. J Neurochem 1995, 65: 2450-2461. 10.1046/j.1471-4159.1995.65062450.xPubMed
27.
Zurück zum Zitat Ladu MJ, Reardon C, Van Eldik L, Fagan AM, Bu G, Holtzman D, Getz GS: Lipoproteins in the central nervous system. Ann N Y Acad Sci 2000, 903: 167-175. 10.1111/j.1749-6632.2000.tb06365.xPubMed Ladu MJ, Reardon C, Van Eldik L, Fagan AM, Bu G, Holtzman D, Getz GS: Lipoproteins in the central nervous system. Ann N Y Acad Sci 2000, 903: 167-175. 10.1111/j.1749-6632.2000.tb06365.xPubMed
28.
Zurück zum Zitat Lopes-Cardozo M, Larsson OM, Schousboe A: Acetoacetate and glucose as lipid precursors and energy substrates in primary cultures of astrocytes and neurons from mouse cerebral cortex. J Neurochem 1986, 46: 773-778. 10.1111/j.1471-4159.1986.tb13039.xPubMed Lopes-Cardozo M, Larsson OM, Schousboe A: Acetoacetate and glucose as lipid precursors and energy substrates in primary cultures of astrocytes and neurons from mouse cerebral cortex. J Neurochem 1986, 46: 773-778. 10.1111/j.1471-4159.1986.tb13039.xPubMed
29.
Zurück zum Zitat Guzman M, Blazquez C: Is there an astrocyte-neuron ketone body shuttle? Trends Endocrinol Metab 2001, 12: 169-173. 10.1016/S1043-2760(00)00370-2PubMed Guzman M, Blazquez C: Is there an astrocyte-neuron ketone body shuttle? Trends Endocrinol Metab 2001, 12: 169-173. 10.1016/S1043-2760(00)00370-2PubMed
30.
Zurück zum Zitat Pellerin L, Pellegri G, Martin JL, Magistretti PJ: Expression of monocarboxylate transporter mRNAs in mouse brain: support for a distinct role of lactate as an energy substrate for the neonatal vs. adult brain. Proc Natl Acad Sci USA 1998, 95: 3990-3995. 10.1073/pnas.95.7.3990PubMedCentralPubMed Pellerin L, Pellegri G, Martin JL, Magistretti PJ: Expression of monocarboxylate transporter mRNAs in mouse brain: support for a distinct role of lactate as an energy substrate for the neonatal vs. adult brain. Proc Natl Acad Sci USA 1998, 95: 3990-3995. 10.1073/pnas.95.7.3990PubMedCentralPubMed
31.
Zurück zum Zitat Pope A: Neurolgia: quantitative aspects. In Dynamic Properties of Glial Cells: An Interdisciplinary Approach to their Study in the Central and Peripheral Nervous System. Edited by: Schoff eniels E, Tower F. New York: Pergamon Press; 1978:13-20. Pope A: Neurolgia: quantitative aspects. In Dynamic Properties of Glial Cells: An Interdisciplinary Approach to their Study in the Central and Peripheral Nervous System. Edited by: Schoff eniels E, Tower F. New York: Pergamon Press; 1978:13-20.
32.
Zurück zum Zitat Leino RL, Gerhart DZ, Duelli R, Enerson BE, Drewes LR: Diet-induced ketosis increases monocarboxylate transporter (MCT1) levels in rat brain. Neurochem Int 2001, 38: 519-527. 10.1016/S0197-0186(00)00102-9PubMed Leino RL, Gerhart DZ, Duelli R, Enerson BE, Drewes LR: Diet-induced ketosis increases monocarboxylate transporter (MCT1) levels in rat brain. Neurochem Int 2001, 38: 519-527. 10.1016/S0197-0186(00)00102-9PubMed
33.
Zurück zum Zitat Hasselbalch SG, Knudsen GM, Jakobsen J, Hageman LP, Holm S, Paulson OB: Brain metabolism during short-term starvation in humans. J Cereb Blood Flow Metab 1994, 14: 125-131.PubMed Hasselbalch SG, Knudsen GM, Jakobsen J, Hageman LP, Holm S, Paulson OB: Brain metabolism during short-term starvation in humans. J Cereb Blood Flow Metab 1994, 14: 125-131.PubMed
34.
Zurück zum Zitat Pan JW, Rothman TL, Behar KL, Stein DT, Hetherington HP: Human brain beta-hydroxybutyrate and lactate increase in fasting-induced ketosis. J Cereb Blood Flow Metab 2000, 20: 1502-1507. 10.1097/00004647-200010000-00012PubMed Pan JW, Rothman TL, Behar KL, Stein DT, Hetherington HP: Human brain beta-hydroxybutyrate and lactate increase in fasting-induced ketosis. J Cereb Blood Flow Metab 2000, 20: 1502-1507. 10.1097/00004647-200010000-00012PubMed
35.
Zurück zum Zitat Pan JW, Telang FW, Lee JH, de Graaf RA, Rothman DL, Stein DT, Hetherington HP: Measurement of beta-hydroxybutyrate in acute hyperketonemia in human brain. J Neurochem 2001, 79: 539-544. 10.1046/j.1471-4159.2001.00575.xPubMed Pan JW, Telang FW, Lee JH, de Graaf RA, Rothman DL, Stein DT, Hetherington HP: Measurement of beta-hydroxybutyrate in acute hyperketonemia in human brain. J Neurochem 2001, 79: 539-544. 10.1046/j.1471-4159.2001.00575.xPubMed
36.
Zurück zum Zitat Kante A, Cherkaoui Malki M, Coquard C, Latruffe N: Metabolic control of the expression of mitochondrial D-beta-hydroxybutyrate dehydrogenase, a ketone body converting enzyme. Biochim Biophys Acta 1990, 1033: 291-297.PubMed Kante A, Cherkaoui Malki M, Coquard C, Latruffe N: Metabolic control of the expression of mitochondrial D-beta-hydroxybutyrate dehydrogenase, a ketone body converting enzyme. Biochim Biophys Acta 1990, 1033: 291-297.PubMed
37.
Zurück zum Zitat Smith AL, Satterthwaite HS, Sokoloff L: Induction of brain D(-)-betahydroxybytrate dehydrogenase activity by fasting. Science 1969, 163: 79-81. 10.1126/science.163.3862.79PubMed Smith AL, Satterthwaite HS, Sokoloff L: Induction of brain D(-)-betahydroxybytrate dehydrogenase activity by fasting. Science 1969, 163: 79-81. 10.1126/science.163.3862.79PubMed
38.
Zurück zum Zitat Gjedde A, Crone C: Induction processes in blood-brain transfer of ketone Bodies during starvation. Am J Physiol 1975, 229: 1165-1169.PubMed Gjedde A, Crone C: Induction processes in blood-brain transfer of ketone Bodies during starvation. Am J Physiol 1975, 229: 1165-1169.PubMed
39.
Zurück zum Zitat Moore TJ, Lione AP, Sugden MC, Regen DM: Beta-hydroxybutyrate transport in rat brain: developmental and dietary modulations. Am J Physiol 1976, 230: 619-630.PubMed Moore TJ, Lione AP, Sugden MC, Regen DM: Beta-hydroxybutyrate transport in rat brain: developmental and dietary modulations. Am J Physiol 1976, 230: 619-630.PubMed
40.
Zurück zum Zitat Hawkins RA, Mans AM, Davis DW: Regional ketone body utilization by rat brain in starvation and diabetes. Am J Physiol 1986, 250: E169-E178.PubMed Hawkins RA, Mans AM, Davis DW: Regional ketone body utilization by rat brain in starvation and diabetes. Am J Physiol 1986, 250: E169-E178.PubMed
41.
Zurück zum Zitat Morris AA: Cerebral ketone body metabolism. J Inherit Metab Dis 2005, 28: 109-121. 10.1007/s10545-005-5518-0PubMed Morris AA: Cerebral ketone body metabolism. J Inherit Metab Dis 2005, 28: 109-121. 10.1007/s10545-005-5518-0PubMed
42.
Zurück zum Zitat Hawkins RA, Biebuyck JF: Ketone bodies are selectively used by individual brain regions. Science 1979, 205: 325-327. 10.1126/science.451608PubMed Hawkins RA, Biebuyck JF: Ketone bodies are selectively used by individual brain regions. Science 1979, 205: 325-327. 10.1126/science.451608PubMed
43.
Zurück zum Zitat Prins ML: Cerebral metabolic adaptation and ketone metabolism after brain injury. J Cereb Blood Flow Metab 2008, 28: 1-16. 10.1038/sj.jcbfm.9600543PubMedCentralPubMed Prins ML: Cerebral metabolic adaptation and ketone metabolism after brain injury. J Cereb Blood Flow Metab 2008, 28: 1-16. 10.1038/sj.jcbfm.9600543PubMedCentralPubMed
44.
Zurück zum Zitat Veech RL, Chance B, Kashiwaya Y, Lardy HA, Cahill GF Jr: Ketone bodies, potential therapeutic uses. IUBMB Life 2001, 51: 241-247. 10.1080/152165401753311780PubMed Veech RL, Chance B, Kashiwaya Y, Lardy HA, Cahill GF Jr: Ketone bodies, potential therapeutic uses. IUBMB Life 2001, 51: 241-247. 10.1080/152165401753311780PubMed
45.
Zurück zum Zitat Kashiwaya Y, Sato K, Tsuchiya N, Thomas S, Fell DA, Veech RL, Passonneau JV: Control of glucose utilization in working perfused rat heart. J Biol Chem 1994, 269: 25502-25514.PubMed Kashiwaya Y, Sato K, Tsuchiya N, Thomas S, Fell DA, Veech RL, Passonneau JV: Control of glucose utilization in working perfused rat heart. J Biol Chem 1994, 269: 25502-25514.PubMed
46.
Zurück zum Zitat Krebs HA, Veech RL: Equilibrium relations between pyridine nucleotides and adenine nucleotides and their roles in the regulation of metabolic processes. Adv Enzyme Regul 1969, 7: 397-413. 10.1016/0065-2571(69)90030-2PubMed Krebs HA, Veech RL: Equilibrium relations between pyridine nucleotides and adenine nucleotides and their roles in the regulation of metabolic processes. Adv Enzyme Regul 1969, 7: 397-413. 10.1016/0065-2571(69)90030-2PubMed
47.
Zurück zum Zitat Ziegler DR, Ribeiro LC, Hagenn M, Siqueira IR, Araujo E, Torres IL, Gottfried C, Netto CA, Goncalves CA: Ketogenic diet increases glutathione peroxidase activity in rat hippocampus. Neurochem Res 2003, 28: 1793-1797. 10.1023/A:1026107405399PubMed Ziegler DR, Ribeiro LC, Hagenn M, Siqueira IR, Araujo E, Torres IL, Gottfried C, Netto CA, Goncalves CA: Ketogenic diet increases glutathione peroxidase activity in rat hippocampus. Neurochem Res 2003, 28: 1793-1797. 10.1023/A:1026107405399PubMed
48.
Zurück zum Zitat Gasior M, Rogawski MA, Hartman AL: Neuroprotective and diseasemodifying effects of the ketogenic diet. Behav Pharmacol 2006, 17: 431-439. 10.1097/00008877-200609000-00009PubMedCentralPubMed Gasior M, Rogawski MA, Hartman AL: Neuroprotective and diseasemodifying effects of the ketogenic diet. Behav Pharmacol 2006, 17: 431-439. 10.1097/00008877-200609000-00009PubMedCentralPubMed
49.
Zurück zum Zitat Yudkoff M, Daikhin Y, Nissim I, Lazarow A: Ketogenic diet, amino acid metabolism, and seizure control. J Neurosci Res 2001, 66: 931-940. 10.1002/jnr.10083PubMed Yudkoff M, Daikhin Y, Nissim I, Lazarow A: Ketogenic diet, amino acid metabolism, and seizure control. J Neurosci Res 2001, 66: 931-940. 10.1002/jnr.10083PubMed
50.
Zurück zum Zitat Hasselbalch SG, Madsen PL, Hageman LP, Olsen KS, Justesen N, Holm S, Paulson OB: Changes in cerebral blood flow and carbohydrate metabolism during acute hyperketonemia. Am J Physiol 1996, 270: E746-E751.PubMed Hasselbalch SG, Madsen PL, Hageman LP, Olsen KS, Justesen N, Holm S, Paulson OB: Changes in cerebral blood flow and carbohydrate metabolism during acute hyperketonemia. Am J Physiol 1996, 270: E746-E751.PubMed
51.
Zurück zum Zitat Prins ML, Giza CC: Induction of monocarboxylate transporter 2 expression and ketone transport following traumatic brain injury in juvenile and adult rats. Dev Neurosci 2006, 28: 447-456. 10.1159/000094170PubMed Prins ML, Giza CC: Induction of monocarboxylate transporter 2 expression and ketone transport following traumatic brain injury in juvenile and adult rats. Dev Neurosci 2006, 28: 447-456. 10.1159/000094170PubMed
52.
Zurück zum Zitat Tieu K, Perier C, Caspersen C, Teismann P, Wu DC, Yan SD, Naini A, Vila M, Jackson-Lewis V, Ramasamy R, Przedborski S: D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. J Clin Invest 2003, 112: 892-901.PubMedCentralPubMed Tieu K, Perier C, Caspersen C, Teismann P, Wu DC, Yan SD, Naini A, Vila M, Jackson-Lewis V, Ramasamy R, Przedborski S: D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. J Clin Invest 2003, 112: 892-901.PubMedCentralPubMed
53.
Zurück zum Zitat Salim A, Hadjizacharia P, Dubose J, Brown C, Inaba K, Chan LS, Margulies D: Persistent hyperglycemia in severe traumatic brain injury: an independent predictor of outcome. Am Surg 2009, 75: 25-29.PubMed Salim A, Hadjizacharia P, Dubose J, Brown C, Inaba K, Chan LS, Margulies D: Persistent hyperglycemia in severe traumatic brain injury: an independent predictor of outcome. Am Surg 2009, 75: 25-29.PubMed
54.
Zurück zum Zitat Maalouf M, Sullivan PG, Davis L, Kim DY, Rho JM: Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience 2007, 145: 256-264. 10.1016/j.neuroscience.2006.11.065PubMedCentralPubMed Maalouf M, Sullivan PG, Davis L, Kim DY, Rho JM: Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience 2007, 145: 256-264. 10.1016/j.neuroscience.2006.11.065PubMedCentralPubMed
55.
Zurück zum Zitat Massieu L, Haces ML, Montiel T, Hernandez-Fonseca K: Acetoacetate protects hippocampal neurons against glutamate-mediated neuronal damage during glycolysis inhibition. Neuroscience 2003, 120: 365-378. 10.1016/S0306-4522(03)00266-5PubMed Massieu L, Haces ML, Montiel T, Hernandez-Fonseca K: Acetoacetate protects hippocampal neurons against glutamate-mediated neuronal damage during glycolysis inhibition. Neuroscience 2003, 120: 365-378. 10.1016/S0306-4522(03)00266-5PubMed
56.
Zurück zum Zitat Mejia-Toiber J, Montiel T, Massieu L: D-β-Hydroxybutyrate prevents glutamate-mediated lipoperoxidation and neuronal damage elicited during glycolysis inhibition in vivo. Neurochem Res 2006, 31: 1399-1408. 10.1007/s11064-006-9189-5PubMed Mejia-Toiber J, Montiel T, Massieu L: D-β-Hydroxybutyrate prevents glutamate-mediated lipoperoxidation and neuronal damage elicited during glycolysis inhibition in vivo. Neurochem Res 2006, 31: 1399-1408. 10.1007/s11064-006-9189-5PubMed
57.
Zurück zum Zitat Noh HS, Kim YS, Kim YH, Han JY, Park CH, Kang AK, Shin HS, Kang SS, Cho GJ, Choi WS: Ketogenic diet protects the hippocampus from kainic acid toxicity by inhibiting the dissociation of bad from 14-3-3. J Neurosci Res 2006, 84: 1829-1836. 10.1002/jnr.21057PubMed Noh HS, Kim YS, Kim YH, Han JY, Park CH, Kang AK, Shin HS, Kang SS, Cho GJ, Choi WS: Ketogenic diet protects the hippocampus from kainic acid toxicity by inhibiting the dissociation of bad from 14-3-3. J Neurosci Res 2006, 84: 1829-1836. 10.1002/jnr.21057PubMed
58.
Zurück zum Zitat Noh HS, Kim YS, Lee HP, Chung KM, Kim DW, Kang SS, Cho GJ, Choi WS: The protective effect of a ketogenic diet on kainic acid-induced hippocampal cell death in the male ICR mice. Epilepsy Res 2003, 53: 119-128. 10.1016/S0920-1211(02)00262-0PubMed Noh HS, Kim YS, Lee HP, Chung KM, Kim DW, Kang SS, Cho GJ, Choi WS: The protective effect of a ketogenic diet on kainic acid-induced hippocampal cell death in the male ICR mice. Epilepsy Res 2003, 53: 119-128. 10.1016/S0920-1211(02)00262-0PubMed
59.
Zurück zum Zitat Masuda R, Monahan JW, Kashiwaya Y: D-β-Hydroxybutyrate is neuroprotective against hypoxia in serum-free hippocampal primary cultures. J Neurosci Res 2005, 80: 501-509. 10.1002/jnr.20464PubMed Masuda R, Monahan JW, Kashiwaya Y: D-β-Hydroxybutyrate is neuroprotective against hypoxia in serum-free hippocampal primary cultures. J Neurosci Res 2005, 80: 501-509. 10.1002/jnr.20464PubMed
60.
Zurück zum Zitat Puchowicz MA, Emancipator DS, Xu K, Magness DL, Ndubuizu OI, Lust WD, LaManna JC: Adaptation to chronic hypoxia during diet-induced ketosis. Adv Exp Med Biol 2005, 566: 51-57. full_textPubMed Puchowicz MA, Emancipator DS, Xu K, Magness DL, Ndubuizu OI, Lust WD, LaManna JC: Adaptation to chronic hypoxia during diet-induced ketosis. Adv Exp Med Biol 2005, 566: 51-57. full_textPubMed
61.
Zurück zum Zitat Hu ZG, Wang HD, Jin W, Yin HX: Ketogenic diet reduces cytochrome c release and cellular apoptosis following traumatic brain injury in juvenile rats. Ann Clin Lab Sci 2009, 39: 76-83.PubMed Hu ZG, Wang HD, Jin W, Yin HX: Ketogenic diet reduces cytochrome c release and cellular apoptosis following traumatic brain injury in juvenile rats. Ann Clin Lab Sci 2009, 39: 76-83.PubMed
62.
Zurück zum Zitat Hu ZG, Wang HD, Qiao L, Yan W, Tan QF, Yin HX: The protective effect of the ketogenic diet on traumatic brain injury-induced cell death in juvenile rats. Brain Injury 2009, 23: 459-465. 10.1080/02699050902788469PubMed Hu ZG, Wang HD, Qiao L, Yan W, Tan QF, Yin HX: The protective effect of the ketogenic diet on traumatic brain injury-induced cell death in juvenile rats. Brain Injury 2009, 23: 459-465. 10.1080/02699050902788469PubMed
63.
Zurück zum Zitat Suzuki M, Suzuki M, Kitamura Y, Mori S, Sato K, Dohi S, Sato T, Matsuura A, Hiraide A: Beta-hydroxybutyrate, a cerebral function improving agent, protects rat brain against ischemic damage caused by permanent and transient focal cerebral ischemia. Jpn J Pharmacol 2002, 89: 36-43. 10.1254/jjp.89.36PubMed Suzuki M, Suzuki M, Kitamura Y, Mori S, Sato K, Dohi S, Sato T, Matsuura A, Hiraide A: Beta-hydroxybutyrate, a cerebral function improving agent, protects rat brain against ischemic damage caused by permanent and transient focal cerebral ischemia. Jpn J Pharmacol 2002, 89: 36-43. 10.1254/jjp.89.36PubMed
64.
Zurück zum Zitat Prins ML, Fujima LS, Hovda DA: Age-dependent reduction of cortical contusion volume by ketones after traumatic brain injury. J Neurosci Res 2005, 82: 413-420. 10.1002/jnr.20633PubMed Prins ML, Fujima LS, Hovda DA: Age-dependent reduction of cortical contusion volume by ketones after traumatic brain injury. J Neurosci Res 2005, 82: 413-420. 10.1002/jnr.20633PubMed
65.
Zurück zum Zitat Prins ML, Lee SM, Fujima LS, Hovda DA: Increased cerebral uptake and oxidation of exogenous betaHB improves ATP following traumatic brain injury in adult rats. J Neurochem 2004, 90: 666-672. 10.1111/j.1471-4159.2004.02542.xPubMed Prins ML, Lee SM, Fujima LS, Hovda DA: Increased cerebral uptake and oxidation of exogenous betaHB improves ATP following traumatic brain injury in adult rats. J Neurochem 2004, 90: 666-672. 10.1111/j.1471-4159.2004.02542.xPubMed
66.
Zurück zum Zitat Hall ED, Andrus PK, Yonkers PA: Brain hydroxyl radical generation in acute experimental head injury. J Neurochem 1993, 60: 588-594. 10.1111/j.1471-4159.1993.tb03189.xPubMed Hall ED, Andrus PK, Yonkers PA: Brain hydroxyl radical generation in acute experimental head injury. J Neurochem 1993, 60: 588-594. 10.1111/j.1471-4159.1993.tb03189.xPubMed
67.
Zurück zum Zitat Biros MH, Nordness R: Eff ects of chemical pretreatment on posttraumatic cortical edema in the rat. Am J Emerg Med 1996, 14: 27-32. 10.1016/S0735-6757(96)90008-XPubMed Biros MH, Nordness R: Eff ects of chemical pretreatment on posttraumatic cortical edema in the rat. Am J Emerg Med 1996, 14: 27-32. 10.1016/S0735-6757(96)90008-XPubMed
68.
Zurück zum Zitat Go KG, Prenen GH, Korf J: Protective effect of fasting upon cerebralhypoxic-ischemic injury. Metab Brain Dis 1988, 3: 257-263. 10.1007/BF00999535PubMed Go KG, Prenen GH, Korf J: Protective effect of fasting upon cerebralhypoxic-ischemic injury. Metab Brain Dis 1988, 3: 257-263. 10.1007/BF00999535PubMed
69.
Zurück zum Zitat Marie C, Bralet AM, Gueldry S, Bralet J: Fasting prior to transient cerebral ischemia reduces delayed neuronal necrosis. Metab Brain Dis 1990, 5: 65-75. 10.1007/BF01001047PubMed Marie C, Bralet AM, Gueldry S, Bralet J: Fasting prior to transient cerebral ischemia reduces delayed neuronal necrosis. Metab Brain Dis 1990, 5: 65-75. 10.1007/BF01001047PubMed
70.
Zurück zum Zitat Suzuki M, Suzuki M, Sato K, Dohi S, Sato T, Matsuura A, Hiraide A: Effect of beta-hydroxybutyrate, a cerebral function improving agent, on cerebral hypoxia, anoxia and ischemia in mice and rats. Jpn J Pharmacol 2001, 87: 143-150. 10.1254/jjp.87.143PubMed Suzuki M, Suzuki M, Sato K, Dohi S, Sato T, Matsuura A, Hiraide A: Effect of beta-hydroxybutyrate, a cerebral function improving agent, on cerebral hypoxia, anoxia and ischemia in mice and rats. Jpn J Pharmacol 2001, 87: 143-150. 10.1254/jjp.87.143PubMed
71.
Zurück zum Zitat Imamura K, Takeshima T, Kashiwaya Y, Nakaso K, Nakashima K: D-β- Hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease. J Neurosci Res 2006, 84: 1376-1384. 10.1002/jnr.21021PubMed Imamura K, Takeshima T, Kashiwaya Y, Nakaso K, Nakashima K: D-β- Hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease. J Neurosci Res 2006, 84: 1376-1384. 10.1002/jnr.21021PubMed
72.
Zurück zum Zitat Kashiwaya Y, Takeshima T, Mori N, Nakashima K, Clarke K, Veech RL: D-β- Hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc Natl Acad Sci USA 2000, 97: 5440-5444. 10.1073/pnas.97.10.5440PubMedCentralPubMed Kashiwaya Y, Takeshima T, Mori N, Nakashima K, Clarke K, Veech RL: D-β- Hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc Natl Acad Sci USA 2000, 97: 5440-5444. 10.1073/pnas.97.10.5440PubMedCentralPubMed
73.
Zurück zum Zitat Kweon GR, Marks JD, Krencik R, Leung EH, Schumacker PT, Hyland K, Kang UJ: Distinct mechanisms of neurodegeneration induced by chronic complex I inhibition in dopaminergic and non-dopaminergic cells. J Biol Chem 2004, 279: 51783-51792. 10.1074/jbc.M407336200PubMed Kweon GR, Marks JD, Krencik R, Leung EH, Schumacker PT, Hyland K, Kang UJ: Distinct mechanisms of neurodegeneration induced by chronic complex I inhibition in dopaminergic and non-dopaminergic cells. J Biol Chem 2004, 279: 51783-51792. 10.1074/jbc.M407336200PubMed
74.
Zurück zum Zitat Van der Auwera I, Wera S, Van Leuven F, Henderson ST: A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease. Nutr Metab (Lond) 2005, 2: 28. 10.1186/1743-7075-2-28 Van der Auwera I, Wera S, Van Leuven F, Henderson ST: A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease. Nutr Metab (Lond) 2005, 2: 28. 10.1186/1743-7075-2-28
75.
Zurück zum Zitat Van Hove JL, Grunewald S, Jaeken J, Demaerel P, Declercq PE, Bourdoux P, Niezen-Koning K, Deanfeld JE, Leonard JV: D, L-3-Hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase defi ciency (MADD). Lancet 2003, 361: 1433-1435. 10.1016/S0140-6736(03)13105-4PubMed Van Hove JL, Grunewald S, Jaeken J, Demaerel P, Declercq PE, Bourdoux P, Niezen-Koning K, Deanfeld JE, Leonard JV: D, L-3-Hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase defi ciency (MADD). Lancet 2003, 361: 1433-1435. 10.1016/S0140-6736(03)13105-4PubMed
76.
Zurück zum Zitat Gilbert DL, Pyzik PL, Freeman JM: The ketogenic diet: seizure control correlates better with serum beta-hydroxybutyrate than with urine ketones. J Child Neurol 2000, 15: 787-790. 10.1177/088307380001501203PubMed Gilbert DL, Pyzik PL, Freeman JM: The ketogenic diet: seizure control correlates better with serum beta-hydroxybutyrate than with urine ketones. J Child Neurol 2000, 15: 787-790. 10.1177/088307380001501203PubMed
77.
Zurück zum Zitat Smith SL, Heal DJ, Martin KF: KTX 0101: a potential metabolic approach to cytoprotection in major surgery and neurological disorders. CNS Drug Rev 2005, 11: 113-140. 10.1111/j.1527-3458.2005.tb00265.xPubMed Smith SL, Heal DJ, Martin KF: KTX 0101: a potential metabolic approach to cytoprotection in major surgery and neurological disorders. CNS Drug Rev 2005, 11: 113-140. 10.1111/j.1527-3458.2005.tb00265.xPubMed
78.
Zurück zum Zitat Ritter AM, Robertson CS, Goodman JC, Contant CF, Grossman RG: Evaluation of a carbohydrate-free diet for patients with severe head injury. J Neurotrauma 1996, 13: 473-485. 10.1089/neu.1996.13.473PubMed Ritter AM, Robertson CS, Goodman JC, Contant CF, Grossman RG: Evaluation of a carbohydrate-free diet for patients with severe head injury. J Neurotrauma 1996, 13: 473-485. 10.1089/neu.1996.13.473PubMed
79.
Zurück zum Zitat Blomqvist G, Alvarsson M, Grill V, Von Heijne G, Ingvar M, Thorell JO, Stone-Elander S, Widen L, Ekberg K: Effect of acute hyperketonemia on the cerebral uptake of ketone bodies in nondiabetic subjects and IDDM patients. Am J Physiol Endocrinol Metab 2002, 283: E20-E28.PubMed Blomqvist G, Alvarsson M, Grill V, Von Heijne G, Ingvar M, Thorell JO, Stone-Elander S, Widen L, Ekberg K: Effect of acute hyperketonemia on the cerebral uptake of ketone bodies in nondiabetic subjects and IDDM patients. Am J Physiol Endocrinol Metab 2002, 283: E20-E28.PubMed
80.
Zurück zum Zitat Dashti HM, Mathew TC, Khadada M, Al-Mousawi M, Talib H, Asfar SK, Behbahani AI, Al-Zaid NS: Beneficial effects of ketogenic diet in obese diabetic subjects. Mol Cell Biochem 2007, 302: 249-256. 10.1007/s11010-007-9448-zPubMed Dashti HM, Mathew TC, Khadada M, Al-Mousawi M, Talib H, Asfar SK, Behbahani AI, Al-Zaid NS: Beneficial effects of ketogenic diet in obese diabetic subjects. Mol Cell Biochem 2007, 302: 249-256. 10.1007/s11010-007-9448-zPubMed
81.
Zurück zum Zitat Hiraide A, Katayama M, Sugimoto H, Yoshioka T, Sugimoto T: Effect of 3-hydroxybutyrate on posttraumatic metabolism in man. Surgery 1991, 109: 176-181.PubMed Hiraide A, Katayama M, Sugimoto H, Yoshioka T, Sugimoto T: Effect of 3-hydroxybutyrate on posttraumatic metabolism in man. Surgery 1991, 109: 176-181.PubMed
82.
Zurück zum Zitat Miles JM, Nissen SL, Rizza RA, Gerich JE, Haymond MW: Failure of infused beta-hydroxybutyrate to decrease proteolysis in man. Diabetes 1983, 32: 197-205. 10.2337/diabetes.32.3.197PubMed Miles JM, Nissen SL, Rizza RA, Gerich JE, Haymond MW: Failure of infused beta-hydroxybutyrate to decrease proteolysis in man. Diabetes 1983, 32: 197-205. 10.2337/diabetes.32.3.197PubMed
83.
Zurück zum Zitat Owen OE, Reichard GA, Markus H, Boden G, Mozzoli MA, Shuman CR: Rapid intravenous sodium acetoacetate infusion in man. Metabolic and kinetic responses. J Clin Invest 1973, 52: 2606-2616. 10.1172/JCI107453PubMedCentralPubMed Owen OE, Reichard GA, Markus H, Boden G, Mozzoli MA, Shuman CR: Rapid intravenous sodium acetoacetate infusion in man. Metabolic and kinetic responses. J Clin Invest 1973, 52: 2606-2616. 10.1172/JCI107453PubMedCentralPubMed
84.
Zurück zum Zitat Reger MA, Henderson ST, Hale C, Cholerton B, Baker LD, Watson GS, Hyde K, Chapman D, Craft S: Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging 2004, 25: 311-314. 10.1016/S0197-4580(03)00087-3PubMed Reger MA, Henderson ST, Hale C, Cholerton B, Baker LD, Watson GS, Hyde K, Chapman D, Craft S: Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging 2004, 25: 311-314. 10.1016/S0197-4580(03)00087-3PubMed
85.
Zurück zum Zitat Hasselbalch SG, Knudsen GM, Jakobsen J, Hageman LP, Holm S, Paulson OB: Blood-brain barrier permeability of glucose and ketone bodies during short-term starvation in humans. Am J Physiol 1995, 268: E1161-E1166.PubMed Hasselbalch SG, Knudsen GM, Jakobsen J, Hageman LP, Holm S, Paulson OB: Blood-brain barrier permeability of glucose and ketone bodies during short-term starvation in humans. Am J Physiol 1995, 268: E1161-E1166.PubMed
86.
Zurück zum Zitat Freeman JM, Vining EP, Pillas DJ, Pyzik PL, Casey JC, Kelly LM: The efficacy of the ketogenic diet - 1998: a prospective evaluation of intervention in 150 children. Pediatrics 1998, 102: 1358-1363. 10.1542/peds.102.6.1358PubMed Freeman JM, Vining EP, Pillas DJ, Pyzik PL, Casey JC, Kelly LM: The efficacy of the ketogenic diet - 1998: a prospective evaluation of intervention in 150 children. Pediatrics 1998, 102: 1358-1363. 10.1542/peds.102.6.1358PubMed
87.
Zurück zum Zitat Kielb S, Koo HP, Bloom DA, Faerber GJ: Nephrolithiasis associated with the ketogenic diet. J Urol 2000, 164: 464-466. 10.1016/S0022-5347(05)67400-9PubMed Kielb S, Koo HP, Bloom DA, Faerber GJ: Nephrolithiasis associated with the ketogenic diet. J Urol 2000, 164: 464-466. 10.1016/S0022-5347(05)67400-9PubMed
88.
Zurück zum Zitat The Brain Trauma Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Initial management J Neurotrauma 2000, 17: 463-469. 10.1089/neu.2000.17.463 The Brain Trauma Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Initial management J Neurotrauma 2000, 17: 463-469. 10.1089/neu.2000.17.463
89.
Zurück zum Zitat Bhardwaj A, Ulatowski JA: Cerebral edema: hypertonic saline solutions. Curr Treat Options Neurol 1999, 1: 179-188. 10.1007/s11940-999-0002-zPubMed Bhardwaj A, Ulatowski JA: Cerebral edema: hypertonic saline solutions. Curr Treat Options Neurol 1999, 1: 179-188. 10.1007/s11940-999-0002-zPubMed
90.
Zurück zum Zitat Harukuni I, Kirsch JR, Bhardwaj A: Cerebral resuscitation: role of osmotherapy. J Anesth 2002, 16: 229-237. 10.1007/s005400200030PubMed Harukuni I, Kirsch JR, Bhardwaj A: Cerebral resuscitation: role of osmotherapy. J Anesth 2002, 16: 229-237. 10.1007/s005400200030PubMed
91.
Zurück zum Zitat Dubick MA, Wade CE: A review of the efficacy and safety of 7.5% NaCl/6% dextran 70 in experimental animals and in humans. J Trauma 1994, 36: 323-330. 10.1097/00005373-199403000-00007PubMed Dubick MA, Wade CE: A review of the efficacy and safety of 7.5% NaCl/6% dextran 70 in experimental animals and in humans. J Trauma 1994, 36: 323-330. 10.1097/00005373-199403000-00007PubMed
92.
Zurück zum Zitat Eilig I, Rachinsky M, Artru AA, Alonchin A, Kapuler V, Tarnapolski A, Shapira Y: The effect of treatment with albumin, hetastarch, or hypertonic saline on neurological status and brain edema in a rat model of closed head trauma combined with uncontrolled hemorrhage and concurrent resuscitation in rats. Anesth Analg 2001, 92: 669-675. 10.1097/00000539-200103000-00023PubMed Eilig I, Rachinsky M, Artru AA, Alonchin A, Kapuler V, Tarnapolski A, Shapira Y: The effect of treatment with albumin, hetastarch, or hypertonic saline on neurological status and brain edema in a rat model of closed head trauma combined with uncontrolled hemorrhage and concurrent resuscitation in rats. Anesth Analg 2001, 92: 669-675. 10.1097/00000539-200103000-00023PubMed
93.
Zurück zum Zitat Gunnar W, Jonasson O, Merlotti G, Stone J, Barrett J: Head injury and hemorrhagic shock: studies of the blood brain barrier and intracranial pressure after resuscitation with normal saline solution, 3% saline solution, and dextran-40. Surgery 1988, 103: 398-407.PubMed Gunnar W, Jonasson O, Merlotti G, Stone J, Barrett J: Head injury and hemorrhagic shock: studies of the blood brain barrier and intracranial pressure after resuscitation with normal saline solution, 3% saline solution, and dextran-40. Surgery 1988, 103: 398-407.PubMed
94.
Zurück zum Zitat Shackford SR: Effect of small-volume resuscitation on intracranial pressure and related cerebral variables. J Trauma 1997, 42: S48-S53. 10.1097/00005373-199705001-00009PubMed Shackford SR: Effect of small-volume resuscitation on intracranial pressure and related cerebral variables. J Trauma 1997, 42: S48-S53. 10.1097/00005373-199705001-00009PubMed
95.
Zurück zum Zitat Berger S, Schurer L, Hartl R, Deisbock T, Dautermann C, Murr R, Messmer K, Baethmann A: 7.2% NaCl/10% dextran 60 versus 20% mannitol for treatment of intracranial hypertension. Acta Neurochir Suppl (Wien) 1994, 60: 494-498. Berger S, Schurer L, Hartl R, Deisbock T, Dautermann C, Murr R, Messmer K, Baethmann A: 7.2% NaCl/10% dextran 60 versus 20% mannitol for treatment of intracranial hypertension. Acta Neurochir Suppl (Wien) 1994, 60: 494-498.
96.
Zurück zum Zitat Mirski AM, Denchev ID, Schnitzer SM, Hanley FD: Comparison between hypertonic saline and mannitol in the reduction of elevated intracranial pressure in a rodent model of acute cerebral injury. J Neurosurg Anesthesiol 2000, 12: 334-344. 10.1097/00008506-200010000-00006PubMed Mirski AM, Denchev ID, Schnitzer SM, Hanley FD: Comparison between hypertonic saline and mannitol in the reduction of elevated intracranial pressure in a rodent model of acute cerebral injury. J Neurosurg Anesthesiol 2000, 12: 334-344. 10.1097/00008506-200010000-00006PubMed
97.
Zurück zum Zitat Cooper DJ, Myles PS, McDermott FT, Murray LJ, Laidlaw J, Cooper G, Tremayne AB, Bernard SS, Ponsford J: Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial. JAMA 2004, 291: 1350-1357. 10.1001/jama.291.11.1350PubMed Cooper DJ, Myles PS, McDermott FT, Murray LJ, Laidlaw J, Cooper G, Tremayne AB, Bernard SS, Ponsford J: Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial. JAMA 2004, 291: 1350-1357. 10.1001/jama.291.11.1350PubMed
98.
Zurück zum Zitat Vassar MJ, Fischer RP, O'Brien PE, Bachulis BL, Chambers JA, Hoyt DB, Holcroft JW: A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Arch Surg 1993, 128: 1003-1011. discussion 1011-1013PubMed Vassar MJ, Fischer RP, O'Brien PE, Bachulis BL, Chambers JA, Hoyt DB, Holcroft JW: A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Arch Surg 1993, 128: 1003-1011. discussion 1011-1013PubMed
99.
Zurück zum Zitat Vassar MJ, Perry CA, Holcroft JW: Prehospital resuscitation of hypotensive trauma patients with 7.5% NaCl versus 7.5% NaCl with added dextran: a controlled trial. J Trauma 1993, 34: 622-632. discussion 632-633 10.1097/00005373-199305000-00003PubMed Vassar MJ, Perry CA, Holcroft JW: Prehospital resuscitation of hypotensive trauma patients with 7.5% NaCl versus 7.5% NaCl with added dextran: a controlled trial. J Trauma 1993, 34: 622-632. discussion 632-633 10.1097/00005373-199305000-00003PubMed
100.
Zurück zum Zitat Qureshi AI, Suarez JI, Bhardwaj A: Malignant cerebral edema in patients with hypertensive intracerebral hemorrhage associated with hypertonic saline infusion: a rebound phenomenon? J Neurosurg Anesthesiol 1998, 10: 188-192. 10.1097/00008506-199807000-00010PubMed Qureshi AI, Suarez JI, Bhardwaj A: Malignant cerebral edema in patients with hypertensive intracerebral hemorrhage associated with hypertonic saline infusion: a rebound phenomenon? J Neurosurg Anesthesiol 1998, 10: 188-192. 10.1097/00008506-199807000-00010PubMed
101.
Zurück zum Zitat Qureshi AI, Suarez JI, Bhardwaj A, Mirski M, Schnitzer MS, Hanley DF, Ulatowski JA: Use of hypertonic (3%) saline/acetate infusion in the treatment of cerebral edema: effect on intracranial pressure and lateral displacement of the brain. Crit Care Med 1998, 26: 440-446. 10.1097/00003246-199803000-00011PubMed Qureshi AI, Suarez JI, Bhardwaj A, Mirski M, Schnitzer MS, Hanley DF, Ulatowski JA: Use of hypertonic (3%) saline/acetate infusion in the treatment of cerebral edema: effect on intracranial pressure and lateral displacement of the brain. Crit Care Med 1998, 26: 440-446. 10.1097/00003246-199803000-00011PubMed
102.
Zurück zum Zitat Chan L, Slater J, Hasbargen J, Herndon DN, Veech RL, Wolf S: Neurocardiac toxicity of racemic D, L-lactate fluids. Integr Physiol Behav Sci 1994, 29: 383-394. 10.1007/BF02691358PubMed Chan L, Slater J, Hasbargen J, Herndon DN, Veech RL, Wolf S: Neurocardiac toxicity of racemic D, L-lactate fluids. Integr Physiol Behav Sci 1994, 29: 383-394. 10.1007/BF02691358PubMed
Metadaten
Titel
Clinical review: Ketones and brain injury
verfasst von
Hayden White
Balasubramanian Venkatesh
Publikationsdatum
01.04.2011
Verlag
BioMed Central
Erschienen in
Critical Care / Ausgabe 2/2011
Elektronische ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc10020

Weitere Artikel der Ausgabe 2/2011

Critical Care 2/2011 Zur Ausgabe

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.